In addition, ATP6V1G3 and COX17 were upregulated in the oxidative phosphorylation pathway and CASP9 was downregulated in the Alzheimer's disease and Parkinson's disease pathways in CKD patients. The gene discussed is CASP9; the disease is Alzheimer disease.